OBJECTIVE: To evaluate the outcome of living related liver transplantation (LRLT) in adult patients and to assess graft size disparity and graft regeneration. SUMMARY BACKGROUND DATA: Although LRLT has been accepted as an optional life-saving procedure for pediatric patients with end-stage liver disease, the feasibility of LRLT for adult patients has not been reported with reference to a clinical series. METHODS: Adult-to-adult LRLT was performed using whole left lobar grafts in 13 patients (5 with primary biliary cirrhosis, 6 with familial amyloid polyneuropathy, 1 with biliary atresia, and 1 with citrullinemia). The 13 donors comprised 5 husbands, 3 sons, 2 sisters, 2 fathers, and 1 mother. The ratio of the graft volume to standard liver volume (GV/SV ratio) was calculated for use as a parameter of graft size disparity. RESULTS: Although the liver graft was markedly small for size (GV/SV ratio 32%-59% at the time of LRLT), none of the 13 patients developed postoperative liver failure. Eleven of the patients are still alive and well with satisfactory graft function 2 to 35 months after LRLT. Graft liver volume increased rapidly after LRLT and approximated the standard liver volume with time. CONCLUSIONS: Our LRLT program for adult patients has produced good results. LRLT in adults can be indicated for selected donor-recipient combinations.
OBJECTIVE: To evaluate the outcome of living related liver transplantation (LRLT) in adult patients and to assess graft size disparity and graft regeneration. SUMMARY BACKGROUND DATA: Although LRLT has been accepted as an optional life-saving procedure for pediatric patients with end-stage liver disease, the feasibility of LRLT for adult patients has not been reported with reference to a clinical series. METHODS: Adult-to-adult LRLT was performed using whole left lobar grafts in 13 patients (5 with primary biliary cirrhosis, 6 with familial amyloid polyneuropathy, 1 with biliary atresia, and 1 with citrullinemia). The 13 donors comprised 5 husbands, 3 sons, 2 sisters, 2 fathers, and 1 mother. The ratio of the graft volume to standard liver volume (GV/SV ratio) was calculated for use as a parameter of graft size disparity. RESULTS: Although the liver graft was markedly small for size (GV/SV ratio 32%-59% at the time of LRLT), none of the 13 patients developed postoperative liver failure. Eleven of the patients are still alive and well with satisfactory graft function 2 to 35 months after LRLT. Graft liver volume increased rapidly after LRLT and approximated the standard liver volume with time. CONCLUSIONS: Our LRLT program for adult patients has produced good results. LRLT in adults can be indicated for selected donor-recipient combinations.
Authors: T G Heffron; A N Langnas; I J Fox; D Mack; A Dhawan; S Kaufman; D Antonsen; T Pillen; D Sudan; J Jerius; J Vanderhoof; J P Donovan; B Shaw Journal: Transplant Proc Date: 1996-08 Impact factor: 1.066
Authors: S Kawasaki; M Makuuchi; H Matsunami; Y Hashikura; T Ikegami; H Chisuwa; T Ikeno; T Noike; T Takayama; H Kawarazaki Journal: Hepatology Date: 1993-11 Impact factor: 17.425
Authors: Y Yamaoka; M Washida; K Honda; K Tanaka; K Mori; Y Shimahara; S Okamoto; M Ueda; M Hayashi; A Tanaka Journal: Transplantation Date: 1994-04-15 Impact factor: 4.939
Authors: Y Hashikura; M Makuuchi; S Kawasaki; H Matsunami; T Ikegami; Y Nakazawa; K Kiyosawa; T Ichida Journal: Lancet Date: 1994-05-14 Impact factor: 79.321
Authors: M Makuuchi; S Kawasaki; T Noguchi; Y Hashikura; H Matsunami; K Hayashi; H Harada; T Kakazu; T Takayama; H Kawarasaki Journal: Surgery Date: 1993-04 Impact factor: 3.982
Authors: K Mori; I Nagata; S Yamagata; H Sasaki; F Nishizawa; Y Takada; F Moriyasu; K Tanaka; Y Yamaoka; K Kumada Journal: Transplantation Date: 1992-08 Impact factor: 4.939
Authors: K Tanaka; S Uemoto; Y Tokunaga; S Fujita; K Sano; T Nishizawa; H Sawada; I Shirahase; H J Kim; Y Yamaoka Journal: Ann Surg Date: 1993-01 Impact factor: 12.969
Authors: C E Broelsch; M Burdelski; X Rogiers; M Gundlach; W T Knoefel; T Langwieler; L Fischer; A Latta; H Hellwege; F J Schulte Journal: Hepatology Date: 1994-07 Impact factor: 17.425
Authors: Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg Journal: J Gastrointest Surg Date: 2004 Mar-Apr Impact factor: 3.452
Authors: Dieter C Broering; Christian Wilms; Christian Lenk; Jan Schulte am Esch; Silke Schönherr; Lars Mueller; Jong-Sun Kim; Knut Helmke; Martin Burdelski; Xavier Rogiers Journal: Ann Surg Date: 2005-12 Impact factor: 12.969
Authors: S Ikeda; M Yazaki; Y Takei; T Ikegami; Y Hashikura; S Kawasaki; M Iwai; K Kobayashi; T Saheki Journal: J Neurol Neurosurg Psychiatry Date: 2001-11 Impact factor: 10.154